<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1235" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1235/" /><meta name="ncbi_pagename" content="Hereditary Multiple Osteochondromas - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hereditary Multiple Osteochondromas - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hereditary Multiple Osteochondromas" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/11/21" /><meta name="citation_author" content="Wim Wuyts" /><meta name="citation_author" content="Gregory A Schmale" /><meta name="citation_author" content="Howard A Chansky" /><meta name="citation_author" content="Wendy H Raskind" /><meta name="citation_pmid" content="20301413" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1235/" /><meta name="citation_keywords" content="Diaphyseal Aclasis" /><meta name="citation_keywords" content="Hereditary Multiple Exostoses" /><meta name="citation_keywords" content="Multiple Cartilaginous Exostoses" /><meta name="citation_keywords" content="Multiple Cartilaginous Exostoses" /><meta name="citation_keywords" content="Diaphyseal Aclasis" /><meta name="citation_keywords" content="Hereditary Multiple Exostoses" /><meta name="citation_keywords" content="Exostosin-1" /><meta name="citation_keywords" content="Exostosin-2" /><meta name="citation_keywords" content="EXT1" /><meta name="citation_keywords" content="EXT2" /><meta name="citation_keywords" content="Hereditary Multiple Osteochondromas" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hereditary Multiple Osteochondromas" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Wim Wuyts" /><meta name="DC.Contributor" content="Gregory A Schmale" /><meta name="DC.Contributor" content="Howard A Chansky" /><meta name="DC.Contributor" content="Wendy H Raskind" /><meta name="DC.Date" content="2013/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1235/" /><meta name="description" content="The disorder hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas (benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones). Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk of malignant degeneration is low (~1%)." /><meta name="og:title" content="Hereditary Multiple Osteochondromas" /><meta name="og:type" content="book" /><meta name="og:description" content="The disorder hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas (benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones). Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk of malignant degeneration is low (~1%)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1235/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ext/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1235/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CF0B0E0404AD100000000051101B8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1235_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1235_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/accpn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hmerf/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1235_"><span class="title" itemprop="name">Hereditary Multiple Osteochondromas</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Diaphyseal Aclasis, Hereditary Multiple Exostoses, Multiple Cartilaginous Exostoses</div><p class="contrib-group"><span itemprop="author">Wim Wuyts</span>, PhD, <span itemprop="author">Gregory A Schmale</span>, MD, <span itemprop="author">Howard A Chansky</span>, MD, and <span itemprop="author">Wendy H Raskind</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1235_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1235_ai__"><div class="contrib half_rhythm"><span itemprop="author">Wim Wuyts</span>, PhD<div class="affiliation small">Department of Medical Genetics<br />University and University Hospital of Antwerp<br />Antwerp, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.neprewtnau@styuw.miw" class="oemail">eb.neprewtnau@styuw.miw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Gregory A Schmale</span>, MD<div class="affiliation small">Associate Professor, Department of Orthopaedics and Sports Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@elamhcsg" class="oemail">ude.wu@elamhcsg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Howard A Chansky</span>, MD<div class="affiliation small">Professor, Department of Orthopaedics and Sports Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@yksnahc" class="oemail">ude.wu@yksnahc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Wendy H Raskind</span>, MD, PhD<div class="affiliation small">Professor, Department of Medicine<br />Division of Medical Genetics<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@nurydnew" class="oemail">ude.wu@nurydnew</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 3, 2000</span>; Last Update: <span itemprop="dateModified">November 21, 2013</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ext.Summary" itemprop="description"><h2 id="_ext_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The disorder hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas (benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones). Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk of malignant degeneration is low (~1%).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HMO is based on clinical and/or radiographic findings of multiple exostoses in one or more members of a family. The two genes in which pathogenic variants are known to cause HMO are <i>EXT1</i> and <i>EXT2</i>. A combination of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis of the entire coding regions of both <i>EXT1</i> and <i>EXT2</i> detects pathogenic variants in 70%-95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Painful lesions in the absence of bone deformity are treated with surgical excision that includes the cartilage cap and overlying perichondrium to prevent recurrence; forearm deformity is treated with excision of the exostoses, corrective osteotomies, and ulnar-lengthening procedures; though uncomplicated resection of osteochondromas in growing children is frequently reported, there is a theoretic risk of growth abnormality resulting from resection of periphyseal osteochondromas; leg-length inequalities greater than 2.5 cm are often treated with epiphysiodesis (growth plate arrest) of the longer leg or lengthening of the involved leg; angular misalignment of the lower limbs may be treated with hemiepiphysiodeses (or osteotomies) at the distal femur, proximal tibia, or distal tibia; early treatment of ankle deformity may prevent or decrease later deterioration of function; sarcomatous degeneration is treated by surgical resection.</p><p><i>Surveillance:</i> Monitoring of the size of exostoses in adults may aid in early identification of malignant degeneration, but no cost/benefit analyses are available to support routine surveillance; a single screening MRI of the spine in children with HMO has been recommended by some to identify spinal lesions that may cause pressure on the spinal cord and would warrant close clinical follow up with excision of those lesions that cause spinal cord impingement and/or symptoms.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>HMO is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Penetrance is approximately 96% in females and 100% in males. In 10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals HMO is the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Offspring of an affected individual are at a 50% risk of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in a family is known.</p></div></div><div id="ext.Diagnosis"><h2 id="_ext_Diagnosis_">Diagnosis</h2><div id="ext.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Hereditary multiple osteochondromas (HMO) are diagnosed clinically in individuals with the following:</p><ul><li class="half_rhythm"><div>Multiple osteochondromas (cartilage-capped bony growths) arising from the area of the growth plate in the juxtaphyseal region of long bones or from the surface of flat bones (e.g., the scapula)</div><ul><li class="half_rhythm"><div>The key radiographic and anatomic feature of an osteochondroma is the uninterrupted flow of cortex and medullary bone from the host bone into the osteochondroma.</div></li><li class="half_rhythm"><div>Osteochondromas possess the equivalent of a growth plate that ossifies and closes with the onset of skeletal maturity.</div></li><li class="half_rhythm"><div>Approximately 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a clinically apparent osteochondroma about the knee, suggesting that radiographs of the knees to detect non-palpable osteochondromas may be a sensitive way to detect mildly affected individuals.</div></li></ul></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance (~10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have no family history of multiple osteochondromas)</div></li></ul><p>Note regarding terminology: Osteochondromas were previously called exostoses; however, the term exostosis is no longer used to describe the lesions in HMO because the term osteochondroma specifies that these lesions are cartilaginous processes that ossify and not simply outgrowths of bone. The changed terminology has been adopted by the World Health Organization (WHO).</p></div><div id="ext.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Genes.</b> The two genes in which pathogenic variants are known to cause HMO are <i>EXT1</i> and <i>EXT2</i>.</p><p><b>Evidence for <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity.</b> One group has suggested that a third <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, <i>EXT3,</i> maps to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 19 [<a class="bk_pop" href="#ext.REF.le_merrer.1994.717">Le Merrer et al 1994</a>]; this linkage association has not been corroborated and may represent a false positive.</p><p><b>Clinical testing.</b> Sequence analysis of the entire coding regions of both <i>EXT1</i> and <i>EXT2</i> detects pathogenic variants in 70%-85% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Performing <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, multiexon, and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions may increase the detection rate to as much as 85%-95% [<a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al 2009</a>]. <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis is not recommended (see <a class="figpopup" href="/books/NBK1235/table/ext.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figextTmoleculargenetictestingusedin" rid-ob="figobextTmoleculargenetictestingusedin">Table 1</a>).</p><div id="ext.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hereditary Multiple Osteochondromas</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1235/table/ext.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ext.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of HMO Attributed to Pathogenic Variants in Gene</th><th id="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Gene and Method&#x000a0;<sup>3,&#x000a0;4</sup></th></tr></thead><tbody><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EXT1</i></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">56%-78%&#x000a0;<sup>5</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup> / scanning for pathogenic variants&#x000a0;<sup>7</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88%-93%</td></tr><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Large deletions</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%-8%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>9</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%-10%</td></tr><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EXT2</i></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">21%-44%&#x000a0;<sup>5</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup> / scanning for pathogenic variants&#x000a0;<sup>7</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-100%</td></tr><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Large deletions</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>9</sup></td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_ext.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%-8%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ext.TF.1.1"><p class="no_margin">See <a href="/books/NBK1235/#ext.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ext.TF.1.2"><p class="no_margin">See <a href="#ext.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="ext.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="ext.TF.1.4"><p class="no_margin">Variant detection frequency reflects a combined approach of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and MLPA for both <i>EXT1</i> and <i>EXT2</i> [<a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al 2009</a>].</p></div></dd><dt>5. </dt><dd><div id="ext.TF.1.5"><p class="no_margin">For review see <a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al [2009]</a>.</p></div></dd><dt>6. </dt><dd><div id="ext.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="ext.TF.1.7"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar variant detection frequencies; however, variant detection rates for scanning may vary considerably between laboratories depending on the specific protocol used. See <a class="bk_pop" href="#ext.REF.wuyts.2005.542">Wuyts et al [2005]</a>, <a class="bk_pop" href="#ext.REF.signori.2007.470">Signori et al [2007]</a>.</p></div></dd><dt>8. </dt><dd><div id="ext.TF.1.8"><p class="no_margin">Not recommended. <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis alone can detect only large deletions and therefore cannot detect the single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions that cause HMO. Note: (1) FISH probes that are commonly used for diagnosis of Langer-Giedion syndrome (also known as trichorhinophalangeal syndrome type II (TRPS2) are not recommended for HMO diagnosis. Langer-Giedion syndrome is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> that includes <i>EXT1</i> as well as <i>TRPS1</i>, the gene in which mutation causes trichorhinophalangeal syndrome type I (TRPS1), and other genes responsible for intellectual disability located near, but outside, <i>EXT1</i> (see <a href="/books/n/gene/tps/">Trichorhinophalangeal Syndrome</a>). (2) FISH probes used for diagnosis of the contiguous gene deletion syndrome known as Potocki-Shaffer syndrome (proximal 11p deletion syndrome; P11pDS; OMIM <a href="http://omim.org/entry/601224" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601224</a>) are not recommended for HMO diagnosis. P11pDS includes <i>EXT2</i> and <i>ALX4</i>, the gene associated with <a href="/books/n/gene/msx2/">enlarged parietal foramina/cranium bifidum type 2</a> (see <a href="#ext.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>).</p></div></dd><dt>9. </dt><dd><div id="ext.TF.1.9"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd></dl></div></div></div></div><div id="ext.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Sequence <i>EXT1</i> first because <i>EXT1</i> pathogenic variants are more frequently detected than <i>EXT2</i> pathogenic variants.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is detected in <i>EXT1</i> by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a><i>,</i>
<i>EXT2</i> should be sequenced.</p></dd><dt>3.</dt><dd><p class="no_top_margin">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in either <i>EXT1</i> or <i>EXT2</i> by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of both genes should be considered.</p></dd></dl><p><b>Prenatal diagnosis</b>
<b>and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a></b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="ext.Clinical_Characteristics"><h2 id="_ext_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ext.Clinical_Description"><h3>Clinical Description</h3><p>The number of osteochondromas, number and location of involved bones, and degree of deformity vary. Osteochondromas grow in size and gradually ossify during skeletal development and stop growing with skeletal maturity, after which no new osteochondromas develop. The proportion of individuals with hereditary multiple osteochondromas (HMO) who have clinical findings increases from approximately 5% at birth to 96% at age 12 years [<a class="bk_pop" href="#ext.REF.legeaimallet.1997.12">Legeai-Mallet et al 1997</a>]. The median age at diagnosis is three years. By adulthood, 75% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a clinically evident bony deformity. Males tend to be more severely affected than females [<a class="bk_pop" href="#ext.REF.pedrini.2011.2294">Pedrini et al 2011</a>]. Most individuals with HMO lead active, healthy lives.</p><p>The number of osteochondromas that develop in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person varies widely even within families. Involvement is usually symmetric. Most commonly involved bones are the femur (30%), radius and ulna (13%), tibia (20%), and fibula (13%). Hand deformity resulting from shortened metacarpals is common. Abnormal bone remodeling may result in shortening and bowing with widened metaphyses [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>].</p><p>In a study of 46 kindreds in Washington State, 39% of individuals had a deformity of the forearm, 10% had an inequality in limb length, 8% had an angular deformity of the knee, and 2% had a deformity of the ankle [<a class="bk_pop" href="#ext.REF.schmale.1994.986">Schmale et al 1994</a>]. Angular deformities (bowing) of the forearm and/or ankle are the most clinically significant orthopedic issues.</p><p>Hip dysplasia may result from osteochondromas of the proximal femur and from coxa valga. Decreased center-edge angles and increased uncovering of the femoral heads may lead to early thigh pain and abductor weakness and late arthritis [<a class="bk_pop" href="#ext.REF.malag_n.2001.205">Malag&#x000f3;n 2001</a>, <a class="bk_pop" href="#ext.REF.ofiram.2004.371">Ofiram &#x00026; Porat 2004</a>]. Femoral-acetabular impingement may also arise from proximal femoral osteochondromas, limiting hip motion [<a class="bk_pop" href="#ext.REF.shin.2009.132">Shin et al 2009</a>, <a class="bk_pop" href="#ext.REF.hussain.2010.51">Hussain et al 2010</a>, <a class="bk_pop" href="#ext.REF.viala.2012.1637">Viala et al 2012</a>].</p><p>It has been stated that 40% of individuals with HMO have "shortened stature." Although interference with the linear growth of the long bones of the leg often results in reduction of predicted adult height, the height of most adults with <i>EXT2</i> pathogenic variants and many with <i>EXT1</i> pathogenic variants falls within the normal range [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>]. Shortened stature is more pronounced in persons with <i>EXT1</i> pathogenic variants [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>, <a class="bk_pop" href="#ext.REF.pedrini.2011.2294">Pedrini et al 2011</a>, <a class="bk_pop" href="#ext.REF.clement.2012.150">Clement et al 2012</a>].</p><p>Note: "Shortened stature" is used to indicate that although stature is often shorter than predicted based on the heights of unaffected parents and sibs, it is usually within the normal range.</p><p>Osteochondromas typically arise in the juxtaphyseal region of long bones and from the surface of flat bones (pelvis, scapula). An osteochondroma may be sessile or pedunculated. Sessile osteochondromas have a broad-based attachment to the cortex. The pedunculated variants have a pedicle arising from the cortex that is usually directed away from the adjacent growth plate. The pedunculated form is more likely to irritate overlying soft tissue, such as tendons, and compress peripheral nerves or vessels. The marrow and cancellous bone of the host bone are continuous with the osteochondroma.</p><p>Symptoms may also arise secondary to mass effect. Compression or stretching of peripheral nerves usually causes pain but may also cause sensory or motor deficits [<a class="bk_pop" href="#ext.REF.hattori.2006.405">Hattori et al 2006</a>]. Spinal cord compression and myelopathy from cervical osteochondromas has been reported [<a class="bk_pop" href="#ext.REF.aldea.2006.195">Aldea et al 2006</a>, <a class="bk_pop" href="#ext.REF.giudicissifilho.2006.s7">Giudicissi-Filho et al 2006</a>, <a class="bk_pop" href="#ext.REF.pandya.2006.e920">Pandya et al 2006</a>]. Mechanical blocks to motion may result from large osteochondromas impinging on the adjacent bone of a joint. Overlying muscles and tendons may be irritated, resulting in pain and loss of motion. Nerves and vessels may be displaced from their normal anatomic course, complicating attempts at surgical removal of osteochondromas. Rarely, urinary or intestinal obstruction results from large pelvic osteochondromas. Thoracic osteochondromas have been reported to lead to diaphragmatic rupture [<a class="bk_pop" href="#ext.REF.abdullah.2006.401">Abdullah et al 2006</a>].</p><p>The most serious complication of HMO is sarcomatous degeneration of an osteochondroma. Axial sites, such as the pelvis, scapula, ribs, and spine, are more commonly the location of degeneration of osteochondromas to chondrosarcoma [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>]. Rapid growth and increasing pain, especially in a physically mature person, are signs of sarcomatous transformation, a potentially life-threatening condition:</p><ul><li class="half_rhythm"><div>A bulky cartilage cap (best visualized with MRI or CT) thicker than 2.0 to 3.0 cm is highly suggestive of chondrosarcoma [<a class="bk_pop" href="#ext.REF.shah.2007.110">Shah et al 2007</a>].</div></li><li class="half_rhythm"><div>After skeletal maturity, increased radionucleotide uptake on serial technetium bone scans may also be evidence of malignancy.</div></li><li class="half_rhythm"><div>High metabolic activity in the cartilage as evidenced by uptake of gadolinum on T<sub>2</sub> MRI may also be indicative of malignancy [<a class="bk_pop" href="#ext.REF.de_beuckeleer.1996.137">De Beuckeleer et al 1996</a>].</div></li><li class="half_rhythm"><div>FDG-PET imaging may be useful in the workup for malignant transformation in HMO. An SUV<sub>max</sub> of 2.0 has been reported as the cutoff above which chondrosarcomatous degeneration of an osteochondroma has likely occurred, although lesions with an SUV<sub>max</sub> as low as 1.3 have been found in Grade I chondrosarcoma [<a class="bk_pop" href="#ext.REF.aoki.1999.603">Aoki et al 1999</a>, <a class="bk_pop" href="#ext.REF.feldman.2005.367">Feldman et al 2005</a>].</div></li></ul><p>The reported incidence of malignant degeneration to chondrosarcoma, or less commonly to other sarcomas, has ranged from 0.5% to 20%, with many reports strongly favoring the lower estimates [<a class="bk_pop" href="#ext.REF.legeaimallet.1997.12">Legeai-Mallet et al 1997</a>]. However, in certain families, the rates of malignant degeneration have been reported to be as high as 6% [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>, <a class="bk_pop" href="#ext.REF.vujic.2004.47">Vujic et al 2004</a>]. In a large cohort of 529 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the rate of malignant transformation was calculated to be 5% [<a class="bk_pop" href="#ext.REF.pedrini.2011.2294">Pedrini et al 2011</a>].</p><p>Malignant degeneration can occur during childhood or adolescence, but the risk increases with age. The prevalence of chondrosarcoma in the general population is approximately one in 250,000 to one in 100,000; however, 5% of those with a chondrosarcoma have HMO. Based on a study of HMO in Washington State (USA), it was estimated that HMO increases the risk of developing a chondrosarcoma by a factor of 1000 to 2500 over the risk for individuals without HMO.</p><p>Note: It is difficult to estimate the actual risk because so many published studies are series from the surgical literature. In the approximately 20 studies over the last 25 years that included <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members of probands (i.e., those who did not themselves present for medical treatment), the rates of sarcomatous degeneration averaged approximately 2%-5%. However, no longitudinal studies have addressed the issue of lifetime risks.</p></div><div id="ext.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Most studies have identified a higher burden of disease in persons with <i>EXT1</i> pathogenic variants than in those with <i>EXT2</i> pathogenic variants:</p><ul><li class="half_rhythm"><div>See findings reported by <a class="bk_pop" href="#ext.REF.francannet.2001.430">Francannet et al [2001]</a>.</div></li><li class="half_rhythm"><div>In a study of 172 individuals from 78 families, <a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al [2004]</a> identified more severe disease in individuals with pathogenic variants in <i>EXT1</i> than in <i>EXT2</i> on the basis of shortened stature, skeletal deformity (shortened forearm or bowing, knee deformity), and function (elbow, forearm, and knee range of motion). The risk of chondrosarcoma may also be higher in individuals with an <i>EXT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>].</div></li><li class="half_rhythm"><div>Persons with <i>EXT1</i> pathogenic variants were found to have a greater number of exostoses, a greater incidence of limb malalignment with shorter limb segments and height, and more frequent pelvic and flat bone involvement than those with <i>EXT2</i> pathogenic variants [<a class="bk_pop" href="#ext.REF.alvarez.2006.122">Alvarez et al 2006</a>].</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#ext.REF.pedrini.2011.2294">Pedrini et al [2011]</a> suggested a clinical classification system based on the presence or absence of deformities and functional limitations (adapted in <a class="bk_pop" href="#ext.REF.mordenti.2013.556">Mordenti et al [2013]</a>). In 529 individuals with multiple osteochondromas (MO) a more severe MO <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was found to be associated with pathogenic variants in <i>EXT1</i> and male sex.</div></li></ul><p>Other studies note no difference in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with pathogenic variants in <i>EXT1</i> versus <i>EXT2</i> but often these studies are limited in study population size [<a class="bk_pop" href="#ext.REF.jennes.2008.85">Jennes et al 2008</a>]. Therefore, the severity of HMO phenotype cannot yet be predicted based on the <i>EXT1</i>/<i>EXT2</i> <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>, as there are other genetic factors that influence the final clinical outcome [<a class="bk_pop" href="#ext.REF.jennes.2012.148">Jennes et al 2012</a>].</p></div><div id="ext.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is estimated to be 96% in females and 100% in males. Most published instances of reduced penetrance have occurred in females. However, comprehensive skeletal radiographs have not been performed in most of these instances.</p></div><div id="ext.Nomenclature"><h3>Nomenclature</h3><p>"Multiple osteocartilaginous exostoses" was used to convey the observation that the growths are composed primarily of cartilage in the child and ossify as skeletal maturity is reached.</p><p>In the United States, the terms "exostosis" and "hereditary multiple exostoses" have been used to denote the growths and the disorder, but the World Health Organization (WHO) has selected the nomenclature "osteochondromas" for exostoses and "multiple osteochondromas" for the disorder [<a class="bk_pop" href="#ext.REF.bov_e.2002">Bov&#x000e9;e &#x00026; Hogendoorn 2002</a>]. These latter terms are preferable as they more precisely describe the lesions as cartilaginous in origin. However, hereditary multiple exostoses (HME) and multiple hereditary exostoses (MHE) are still frequently used as abbreviations for this disorder, and the genes are named exostosin-1 (<i>EXT1</i>) and exostosin-2 (<i>EXT2</i>).</p></div><div id="ext.Prevalence"><h3>Prevalence</h3><p>The reported prevalence of HMO ranges from as high as one in 100 in a small population in Guam to approximately one in 100,000 in European populations [<a class="bk_pop" href="#ext.REF.krooth.1961.340">Krooth et al 1961</a>, <a class="bk_pop" href="#ext.REF.hennekam.1991.262">Hennekam 1991</a>]. The prevalence has been estimated to be at least one in 50,000 in Washington State [<a class="bk_pop" href="#ext.REF.schmale.1994.986">Schmale et al 1994</a>].</p></div></div><div id="ext.Genetically_Related_Allelic_Disorder"><h2 id="_ext_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are associated with mutation of <i>EXT1</i> or <i>EXT2</i>.</p><p>However, two <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> syndromes include multiple osteochondromas as one characteristic:</p><ul><li class="half_rhythm"><div>Langer-Giedion syndrome involving <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>EXT1</i> and <i>TRPS1</i> at 8q24.11-q24.13 (see <a href="/books/n/gene/tps/">Trichorhinophalangeal Syndrome</a> and <a href="#ext.Differential_Diagnosis">Differential Diagnosis</a>)</div></li><li class="half_rhythm"><div>Potocki-Shaffer syndrome, also known as proximal 11p <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> (P11pDS), involving deletion of <i>EXT2</i> and <i>ALX4</i> at 11p11.2 (see also <a href="#ext.Differential_Diagnosis">Differential Diagnosis</a>)</div></li></ul></div><div id="ext.Differential_Diagnosis"><h2 id="_ext_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Solitary osteochrondroma.</b> Skeletal surveys suggest that a solitary osteochondroma, a common benign bone tumor, can be found in 1%-2% of the population. Solitary osteochondromas demonstrate growth patterns similar to those of multiple osteochondromas. Conditions that may be confused with a solitary osteochondroma include juxtacortical osteosarcoma, soft tissue osteosarcoma, and heterotopic ossification. Plain radiographs or CT are often helpful in distinguishing these lesions from osteochondromas. Typically, none of these conditions displays the continuity of cancellous and cortical bone from the host bone to the lesion characteristic of hereditary multiple osteochondromas (HMO).</p><p>Three inherited conditions in which multiple osteochondromas occur:</p><ul><li class="half_rhythm"><div><b>Metachondromatosis</b> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. In contrast to HMO, metachondromatosis is characterized by both osteochondromas and intraosseous enchondromas. The osteochondromas of metachondromatosis occur predominantly in the digits and, unlike those of HMO, point toward the nearby joint and do not cause shortening or bowing of the long bone, joint deformity, or subluxation. Metachondromatosis is caused by mutation of <i>PTPN11</i> [<a class="bk_pop" href="#ext.REF.bowen.2011.e1002050">Bowen et al 2011</a>].</div></li><li class="half_rhythm"><div><b>Langer-Giedion syndrome</b> is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> involving <i>EXT1</i>. Affected individuals have intellectual disability and characteristic craniofacial and digital anomalies. Skeletal abnormalities result from <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>TRPS1</i>, the gene responsible for trichorhinophalangeal syndrome type I (TRSP1). See <a href="/books/n/gene/tps/">Trichorhinophalangeal Syndrome</a>.</div></li><li class="half_rhythm"><div><b>11p11 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a></b> (formerly known as DEFECT 11 or Potocki-Shaffer syndrome) (OMIM <a href="http://omim.org/entry/601224" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601224</a>) is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> involving <i>EXT2</i> and <i>ALX4</i> (OMIM <a href="http://omim.org/entry/168500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">168500</a>). Deletion of <i>ALX4</i> results in parietal foramina and ossification defects of the skull (see <a href="/books/n/gene/msx2/">Enlarged Parietal Foramina/Cranium Bifidum</a>). As-yet unidentified genes are responsible for the craniofacial abnormalities, syndactyly, and intellectual disability seen in some cases [<a class="bk_pop" href="#ext.REF.romeike.2007.1">Romeike &#x00026; Wuyts 2007</a>].</div></li></ul></div><div id="ext.Management"><h2 id="_ext_Management_">Management</h2><div id="ext.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with hereditary multiple osteochondromas (HMO), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Detailed history of symptoms from osteochondromas</div></li><li class="half_rhythm"><div>Physical examination to document location of osteochondromas, functional limitations, and deformity (shortness of stature, forearm bowing and shortening, knee and ankle angular deformities)</div></li><li class="half_rhythm"><div>Consulation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ext.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Osteochondromas require no therapy in the absence of clinical problems.</p><p>Angular deformities, leg-length inequalities, and pain resulting from irritation of skin, tendons, or nerves often require surgery. Most individuals with HMO have at least one operative procedure and many have multiple procedures [<a class="bk_pop" href="#ext.REF.porter.2004.1041">Porter et al 2004</a>]:</p><ul><li class="half_rhythm"><div>Painful lesions without bony deformity can be treated with simple surgical excision. Excision of osteochondromas may also slow the growth disturbance and improve cosmesis and must include the cartilage cap and overlying perichondrium to avoid recurrence.</div></li><li class="half_rhythm"><div>Surgery for forearm deformity may involve excision of the osteochondromas, corrective osteotomies, and/or ulnar lengthening procedures that may improve pronation, supination, and forearm alignment [<a class="bk_pop" href="#ext.REF.matsubara.2006.459">Matsubara et al 2006</a>, <a class="bk_pop" href="#ext.REF.shin.2006.255">Shin et al 2006</a>, <a class="bk_pop" href="#ext.REF.ishikawa.2007.1238">Ishikawa et al 2007</a>, <a class="bk_pop" href="#ext.REF.watts.2007.667">Watts et al 2007</a>]; however, adults with HMO and untreated forearm deformities describe few functional limitations.</div></li><li class="half_rhythm"><div>Though uncomplicated resection of osteochondromas in growing children is frequently reported [<a class="bk_pop" href="#ext.REF.fogel.1984.670">Fogel et al 1984</a>, <a class="bk_pop" href="#ext.REF.danielsson.1990.469">Danielsson et al 1990</a>, <a class="bk_pop" href="#ext.REF.shin.2006.255">Shin et al 2006</a>, <a class="bk_pop" href="#ext.REF.ishikawa.2007.1238">Ishikawa et al 2007</a>], there is a theoretic risk of growth abnormality resulting from resection of periphyseal osteochondromas.</div><ul><li class="half_rhythm"><div>Abnormal growth and development of the forearm and leg in <i>untreated</i> individuals with HMO is common, including both proportionate and disproportionate shortening of the two bones of the forearm or leg, producing shortened and angulated limbs, respectively.</div></li><li class="half_rhythm"><div>Waiting to resect osteochondromas until they have migrated away from the physis would decrease the risk of injury to the physis, as well as potentially limiting the likelihood of recurrence of lesions [<a class="bk_pop" href="#ext.REF.chin.2000.1269">Chin et al 2000</a>, <a class="bk_pop" href="#ext.REF.shin.2006.255">Shin et al 2006</a>]. However, numerous studies suggest that early treatment (in individuals age &#x0003c;10 years) of forearm deformities via resection of distal osteochondromas may decrease proportionate shortening and bowing of the forearm [<a class="bk_pop" href="#ext.REF.masada.1989.24">Masada et al 1989</a>, <a class="bk_pop" href="#ext.REF.ishikawa.2007.1238">Ishikawa et al 2007</a>] as well as deformity about the ankle [<a class="bk_pop" href="#ext.REF.chin.2000.1269">Chin et al 2000</a>].</div></li></ul></li><li class="half_rhythm"><div>Leg-length inequalities greater than 2.5 cm are often treated with epiphysiodesis (growth plate arrest) of the longer leg.</div></li><li class="half_rhythm"><div>Angular misalignment of the lower limbs may be treated with hemiepiphysiodeses (or osteotomies) at the distal femur, proximal tibia, or distal tibia [<a class="bk_pop" href="#ext.REF.ofiram.2008.11">Ofiram et al 2008</a>, <a class="bk_pop" href="#ext.REF.boero.2011.209">Boero et al 2011</a>, <a class="bk_pop" href="#ext.REF.rupprecht.2011.89">Rupprecht et al 2011</a>, <a class="bk_pop" href="#ext.REF.tompkins.2012.e23">Tompkins et al 2012</a>, <a class="bk_pop" href="#ext.REF.driscoll.2013.1267">Driscoll et al 2013</a>].</div></li><li class="half_rhythm"><div>Early surgical treatment of tibio talar tilt may prevent or decrease the incidence of late deterioration of ankle function; long-term follow-up studies are needed [<a class="bk_pop" href="#ext.REF.noonan.2002.120">Noonan et al 2002</a>].</div></li><li class="half_rhythm"><div>Surgical resection is the treatment for sarcomatous degeneration. Adjuvant radiotherapy and chemotherapy are controversial for secondary chondrosarcoma, but are often used in the setting of a secondary osteosarcoma.</div></li></ul></div><div id="ext.Surveillance"><h3>Surveillance</h3><p>Monitoring of the size of adult osteochondromas, in particular those involving the pelvis or scapula, may aid in early identification of malignant degeneration, but no cost/benefit analyses are available to support routine surveillance.</p><p>Radiography, CT scanning, MRI, positron emission tomography and technicium-99 radionuclide imaging can be used to evaluate centrally located osteochondromas, but it is not known whether the benefits outweigh the risks of irradiation and the potential for false positive results that lead to unnecessary interventions. In addition, optimal screening intervals have not been determined.</p><p>A single screening MRI of the spine in children with HMO has been recommended by some [<a class="bk_pop" href="#ext.REF.roach.2009.1942">Roach et al 2009</a>] to identify spinal lesions that may cause pressure on the spinal cord. The presence of osteochondromas in the canal would then warrant close clinical follow up; encroaching lesions and those causing symptoms may merit excision.</p></div><div id="ext.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Presymptomatic testing is not warranted because the clinical diagnosis is evident at an early age and because no precipitants, protective strategies, or specific nonsurgical interventions are known.</p><p>See <a href="#ext.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ext.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ext.Genetic_Counseling"><h2 id="_ext_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ext.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The disorder hereditary multiple osteochondromas (HMO) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="ext.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Approximately 90% of individuals with HMO have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; approximately 10% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of an individual with <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> HMO (i.e., a single occurrence in a family) include physical examination, radiographs, and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>Note: Although 90% of individuals diagnosed with HMO have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members and/or decreased <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>Because most probands have a parent with the altered <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with HMO usually have a 50% chance of inheriting the gene alteration; sibs who inherit the alteration have a 95% chance of manifesting symptoms.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected or the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA of either parent, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has been described for this disorder and should be taken into account [<a class="bk_pop" href="#ext.REF.szuhai.2011.e2036">Szuhai et al 2011</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring have a 50% chance of inheriting the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="ext.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Consideration in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, parental <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> needs to be considered; possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ext.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HMO are possible.</p><p>Differences in perspective may exist among medical professionals and families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ext.Resources"><h2 id="_ext_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>MHE and Me</b></div><div>14 Stony Brook Drive</div><div>Pine Island NY 10969</div><div><b>Phone:</b> 845-258-6058</div><div><b>Email:</b> mheandme@yahoo.com</div><div><a href="https://www.mhecoalition.org/mhe-and-me" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mhecoalition.org</a></div></li><li class="half_rhythm"><div><b>MHE Research Foundation</b></div><div><b>Phone:</b> 917-848-7774</div><div><b>Email:</b> mhefuntasia@gmail.com</div><div><a href="https://www.mherf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mherf.org</a></div></li></ul></div><div id="ext.Molecular_Genetics"><h2 id="_ext_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ext.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hereditary Multiple Osteochondromas: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1235/table/ext.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ext.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ext.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ext.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ext.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ext.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ext.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ext.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ext.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2131" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EXT1</i></a></td><td headers="hd_b_ext.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2131" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q24<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q16394" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Exostosin-1</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/EXT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT1 gene database</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EXT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT1</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EXT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT1</a></td></tr><tr><td headers="hd_b_ext.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2132" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EXT2</i></a></td><td headers="hd_b_ext.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2132" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q93063" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Exostosin-2</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/EXT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT2 gene homepage</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EXT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT2</a></td><td headers="hd_b_ext.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EXT2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EXT2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ext.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ext.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hereditary Multiple Osteochondromas (<a href="/omim/133700,133701,608177,608210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1235/table/ext.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ext.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXOSTOSES, MULTIPLE, TYPE I; EXT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133701" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133701</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXOSTOSES, MULTIPLE, TYPE II; EXT2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608177" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608177</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXOSTOSIN GLYCOSYLTRANSFERASE 1; EXT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608210</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXOSTOSIN GLYCOSYLTRANSFERASE 2; EXT2</td></tr></tbody></table></div></div><div id="ext.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Both <i>EXT</i> (<i>EXT1</i>, <i>EXT2</i>) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> products are involved in the biosynthesis of heparan sulfate. <i>EXT1</i> and <i>EXT2</i> encode glycosyltransferases that interact as heterooligomeric complexes [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>]. Pathogenic variants in <i>EXT1</i> or <i>EXT2</i> cause cytoskeletal abnormalities that include actin accumulation, excessive bundling by alpha-actinin, and abnormal presence of muscle-specific alpha-actin [<a class="bk_pop" href="#ext.REF.bernard.2000.442">Bernard et al 2000</a>]. Some evidence suggests that <i>EXT1</i> and <i>EXT2</i> may have tumor suppressor activity [<a class="bk_pop" href="#ext.REF.hecht.1997.80">Hecht et al 1997</a>].</p><p>A two-hit mutation model was proposed for <i>EXT1</i> and <i>EXT2</i> in the formation of osteochondromas, based on the observation of <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> in chondrosarcomas [<a class="bk_pop" href="#ext.REF.hecht.1997.80">Hecht et al 1997</a>, <a class="bk_pop" href="#ext.REF.philippe.1997.520">Philippe et al 1997</a>] and the identification of <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>EXT1</i> deletions in solitary osteochondromas [<a class="bk_pop" href="#ext.REF.hameetman.2007.396">Hameetman et al 2007</a>]. Osteochondroma mouse models [<a class="bk_pop" href="#ext.REF.jones.2010.2054">Jones et al 2010</a>, <a class="bk_pop" href="#ext.REF.matsumoto.2010.10932">Matsumoto et al 2010</a>] have shown that complete inactivation of both <i>Ext1</i> alleles in a small fraction of chondrocytes is sufficient for the development of osteochondromas and other skeletal defects associated with MHO and that osteochondromas are composed of a mixture of EXT<sup>+/-</sup> and EXT<sup>-/-</sup> cells. The failure to identify pathogenic variants in both alleles of <i>EXT1</i> and/or <i>EXT2</i> or loss of heterozygosity in osteochondromas of individuals with hereditary multiple osteochondromas (HMO) in some studies [<a class="bk_pop" href="#ext.REF.hall.2002.1">Hall et al 2002</a>, <a class="bk_pop" href="#ext.REF.zuntini.2010.3827">Zuntini et al 2010</a>] may be caused by the limitations of <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the detection test used or may suggest alternative mechanisms for osteochondroma formation. Epigenetic loss of <i>EXT1</i> activity through hypermethylation has been observed in leukemias and other cancers, further supporting a tumor suppressor role for this <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a> [<a class="bk_pop" href="#ext.REF.ropero.2004.2753">Ropero et al 2004</a>].</p><p><i>EXT1</i> and <i>EXT2</i> are related to the <i>EXTL</i> family of genes by sequence homology. At present the <i>EXTL</i> family consists of three members (<a class="figpopup" href="/books/NBK1235/table/ext.T.extl_gene_family/?report=objectonly" target="object" rid-figpopup="figextTextlgenefamily" rid-ob="figobextTextlgenefamily">Table 2</a>) but to date these genes have not been shown to be involved in osteochondroma development.</p><div id="ext.T.extl_gene_family" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>EXTL</i> Gene Family</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1235/table/ext.T.extl_gene_family/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ext.T.extl_gene_family_lrgtbl__"><table><thead><tr><th id="hd_h_ext.T.extl_gene_family_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_ext.T.extl_gene_family_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Locus</th><th id="hd_h_ext.T.extl_gene_family_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th><th id="hd_h_ext.T.extl_gene_family_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ext.T.extl_gene_family_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EXTL1</i></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1p36.1</td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ext.REF.wise.1997.10">Wise et al [1997]</a></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not associated w/any disease</td></tr><tr><td headers="hd_h_ext.T.extl_gene_family_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EXTL2</i></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1p12-p11</td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ext.REF.wuyts.1997.382">Wuyts et al [1997]</a></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LOH in osteochondromas [<a class="bk_pop" href="#ext.REF.bov_e.1999.689">Bov&#x000e9;e et al 1999</a>]</td></tr><tr><td headers="hd_h_ext.T.extl_gene_family_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EXTL3</i></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8p21</td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ext.REF.van_hul.1998.230">Van Hul et al [1998]</a></td><td headers="hd_h_ext.T.extl_gene_family_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants found in colorectal tumors [<a class="bk_pop" href="#ext.REF.arai.1999.915">Arai et al 1999</a>]</td></tr></tbody></table></div></div><p>Not only do <i>EXT1</i> and <i>EXT2</i> code for transmembrane glycoproteins that together form a heterooligomeric heparan sulfate polymerase; the protein product also participates in cell signaling and chondrocyte proliferation and differentiation [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>, <a class="bk_pop" href="#ext.REF.senay.2000.282">Senay et al 2000</a>, <a class="bk_pop" href="#ext.REF.bernard.2001.149">Bernard et al 2001</a>, <a class="bk_pop" href="#ext.REF.hall.2002.1">Hall et al 2002</a>]. Study of heparan sulfate proteoglycan (HSPG) synthesis in <i>Drosophila</i> suggests that a parallel signaling pathway may exist in humans [<a class="bk_pop" href="#ext.REF.bellaiche.1998.85">Bellaiche et al 1998</a>].</p><div id="ext.EXT1"><h4><i>EXT1</i></h4><p><b>Gene structure.</b>
<i>EXT1</i> contains 11 exons spanning 250 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1235/#ext.molgen.TA">Table A</a>, <b>Gene.</b></p><p><b>Pathogenic variants.</b> More than 400 different pathogenic variants have been described in <i>EXT1</i>, listed in the Multiple Osteochondromas Mutation Database (Modb) [<a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al 2009</a>]. These pathogenic variants are dispersed throughout the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and most are predicted to result in premature termination of the <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>. Only a few of the pathogenic variants have been identified in more than one family. There are several relative hot spots for mutation. Exons 1 and 6 contain one and two polypyrimidine tracts, respectively, which are often sites of frameshift variants. Missense variants cluster in codons 339 and 340. Pathogenic variants in the carboxy-terminal region are relatively sparse. Whole-gene, partial-gene, and single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions have been described but there are no recurrent break points [<a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al 2009</a>, <a class="bk_pop" href="#ext.REF.jennes.2011.85">Jennes et al 2011</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Exostosin-1 comprises 746 amino acids and is involved in heparan sulfate synthesis. It is a type II transmembrane glycoprotein that localizes to the endoplasmic reticulum [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>]. Exostosin-1 and exostosin-2 form a heterooligomeric complex that accumulates in the Golgi apparatus and has substantially higher glycosyltransferase activity than exostosin-1 or exostosin-2 alone [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have also been observed. Most of the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants detected occur in residues that are highly conserved evolutionarily and are thought to be crucial for the activity of the protein. The clinical significance of pathogenic missense variants affecting residues that are not as highly conserved is uncertain, as they may be rare normal variants.</p></div><div id="ext.EXT2"><h4><i>EXT2</i></h4><p><b>Gene structure.</b>
<i>EXT2</i> contains 14 exons plus two alternative exons spanning 110 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1235/#ext.molgen.TA">Table A</a>, <b>Gene.</b></p><p><b>Pathogenic variants.</b> More than 200 pathogenic variants have been found in <i>EXT2</i>, listed in the Multiple Osteochondromas Mutation Database (Modb) [<a class="bk_pop" href="#ext.REF.jennes.2009.1620">Jennes et al 2009</a>]. The pathogenic variants are mainly located in the first eight exons and are mainly <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants (frameshift, <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>). Few <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported in <i>EXT2</i>. Some missense variants occur in evolutionarily conserved residues, have been seen in more than one family with HMO, and are likely to be pathogenic. Very few pathogenic variants have been found in the carboxy-terminal region of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein comprises 718 amino acids. Like exostosin-1, exostosin-2 is a type II transmembrane glycoprotein that localizes to the endoplasmic reticulum and is involved in heparan sulfate synthesis [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>]. Exostosin-1 and exostosin-2 form a heterooligomeric complex that accumulates in the Golgi apparatus and has substantially higher glycosyltransferase activity than exostosin-1 or exostosin-2 alone [<a class="bk_pop" href="#ext.REF.mccormick.2000.668">McCormick et al 2000</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants are predicted to result in premature chain termination and loss of gene function.</p></div></div></div><div id="ext.References"><h2 id="_ext_References_">References</h2><div id="ext.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ext.REF.abdullah.2006.401">Abdullah F, Kanard R, Femino D, Ford H, Stein J. Osteochondroma causing diaphragmatic rupture and bowel obstruction in a 14-year-old boy. <span><span class="ref-journal">Pediatr Surg Int. </span>2006;<span class="ref-vol">22</span>:401–3.</span> [<a href="/pubmed/16395607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16395607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.aldea.2006.195">Aldea S, Bonneville F, Poirier J, Chiras J, George B, Carpentier A. Acute spinal cord compression in hereditary multiple exostoses. <span><span class="ref-journal">Acta Neurochir (Wien). </span>2006;<span class="ref-vol">148</span>:195–8.</span> [<a href="/pubmed/16311838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16311838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.alvarez.2006.122">Alvarez C, Tredwell S, De Vera M, Hayden M. The genotype-phenotype correlation of hereditary multiple exostoses. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">70</span>:122–30.</span> [<a href="/pubmed/16879194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16879194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.aoki.1999.603">Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. <span><span class="ref-journal">J Comput Assist Tomogr. </span>1999;<span class="ref-vol">23</span>:603–8.</span> [<a href="/pubmed/10433294" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10433294</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.arai.1999.915">Arai T, Akiyama Y, Nagasaki H, Murase N, Okabe S, Ikeuchi T, Saito K, Iwai T, Yuasa Y. EXTL3/EXTR1 alterations in colorectal cancer cell lines. <span><span class="ref-journal">Int J Oncol. </span>1999;<span class="ref-vol">15</span>:915–9.</span> [<a href="/pubmed/10536173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10536173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bellaiche.1998.85">Bellaiche Y, et al.  Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">394</span>:85–8.</span> [<a href="/pubmed/9665133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9665133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bernard.2001.149">Bernard MA, Hall CE, Hogue DA, Cole WG, Scott A, Snuggs MB, Clines GA, Ludecke HJ, Lovett M, Van Winkle WB, Hecht JT. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. <span><span class="ref-journal">Cell Motil Cytoskeleton. </span>2001;<span class="ref-vol">48</span>:149–62.</span> [<a href="/pubmed/11169766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11169766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bernard.2000.442">Bernard MA, Hogue DA, Cole WG, Sanford T, Snuggs MB, Montufar-Solis D, Duke PJ, Carson DD, Scott A, Van Winkle WB, Hecht JT. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. <span><span class="ref-journal">J Bone Miner Res. </span>2000;<span class="ref-vol">15</span>:442–50.</span> [<a href="/pubmed/10750558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10750558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.boero.2011.209">Boero S, Michelis MB, Riganti S. Use of the eight-Plate for angular correction of knee deformities due to idiopathic and pathologic physis: initiating treatment according to etiology. <span><span class="ref-journal">J Child Orthop. </span>2011;<span class="ref-vol">5</span>:209–16.</span> [<a href="/pmc/articles/PMC3100457/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3100457</span></a>] [<a href="/pubmed/22654982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22654982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bov_e.1999.689">Bov&#x000e9;e JV, Cleton-Jansen AM, Wuyts W, Caethoven G, Taminiau AH, Bakker E, Van Hul W, Cornelisse CJ, Hogendoorn PC. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:689–98.</span> [<a href="/pmc/articles/PMC1377975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377975</span></a>] [<a href="/pubmed/10441575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10441575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bov_e.2002">Bov&#x000e9;e JVMG, Hogendoorn PCW. Multiple osteochondromas. In: Fletcher CDM, Unni KK, Mertens F, eds. <em>World Health Organization. Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone.</em> Lyon, France: IARC Press; 2002:360-2.</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.bowen.2011.e1002050">Bowen ME, Boyden ED, Holm IA, Campos-Xavier B, Bonaf&#x000e9; L, Superti-Furga A, Ikegawa S, Cormier-Daire V, Bov&#x000e9;e JV, Pansuriya TC, de Sousa SB, Savarirayan R, Andreucci E, Vikkula M, Garavelli L, Pottinger C, Ogino T, Sakai A, Regazzoni BM, Wuyts W, Sangiorgi L, Pedrini E, Zhu M, Kozakewich HP, Kasser JR, Seidman JG, Kurek KC, Warman ML. Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002050.</span> [<a href="/pmc/articles/PMC3077396/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3077396</span></a>] [<a href="/pubmed/21533187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21533187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.chin.2000.1269">Chin KR, Kharrazi FD, Miller BS, Mankin HJ, Gebhardt MC. Osteochondromas of the distal aspect of the tibia or fibula. Natural history and treatment. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2000;<span class="ref-vol">82</span>:1269–78.</span> [<a href="/pubmed/11005518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11005518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.clement.2012.150">Clement ND, Duckworth AD, Baker AD, Porter DE. Skeletal growth patterns in hereditary multiple exostoses: a natural history. <span><span class="ref-journal">J Pediatr Orthop B. </span>2012;<span class="ref-vol">21</span>:150–4.</span> [<a href="/pubmed/22139142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22139142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.danielsson.1990.469">Danielsson LG, el-Haddad I, Quadros O. Distal tibial osteochondroma deforming the fibula. <span><span class="ref-journal">Acta Orthop Scand. </span>1990;<span class="ref-vol">61</span>:469–70.</span> [<a href="/pubmed/2239177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2239177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.de_beuckeleer.1996.137">De Beuckeleer LH, De Schepper AM, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? <span><span class="ref-journal">Skeletal Radiol. </span>1996;<span class="ref-vol">25</span>:137–41.</span> [<a href="/pubmed/8848742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8848742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.driscoll.2013.1267">Driscoll M, Linton J, Sullivan E, Scott A. Correction and recurrence of ankle valgus in skeletally immature patients with multiple hereditary exostoses. <span><span class="ref-journal">Foot Ankle Int. </span>2013;<span class="ref-vol">34</span>:1267–73.</span> [<a href="/pubmed/23598856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23598856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.feldman.2005.367">Feldman F, Van Heertum R, Saxena C, Parisien M. 18FDG-PET applications for cartilage neoplasms. <span><span class="ref-journal">Skeletal Radiol. </span>2005;<span class="ref-vol">34</span>:367–74.</span> [<a href="/pubmed/15937711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15937711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.fogel.1984.670">Fogel GR, McElfresh EC, Peterson HA, Wicklund PT. Management of deformities of the forearm in multiple hereditary osteochondromas. <span><span class="ref-journal">J Bone Joint Surg Am. </span>1984;<span class="ref-vol">66</span>:670–80.</span> [<a href="/pubmed/6725315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6725315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.francannet.2001.430">Francannet C, Cohen-Tanugi A, Le Merrer M, Munnich A, Bonaventure J, Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. <span><span class="ref-journal">J Med Genet. </span>2001;<span class="ref-vol">38</span>:430–4.</span> [<a href="/pmc/articles/PMC1757186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757186</span></a>] [<a href="/pubmed/11432960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11432960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.giudicissifilho.2006.s7">Giudicissi-Filho M, de Holanda CV, Borba LA, Rassi-Neto A, Ribeiro CA, de Oliveira JG. Cervical spinal cord compression due to an osteochondroma in hereditary multiple exostosis: case report and review of the literature. <span><span class="ref-journal">Surg Neurol. </span>2006;<span class="ref-vol">66</span> Suppl 3:S7–S11.</span> [<a href="/pubmed/17081854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17081854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hall.2002.1">Hall CR, Cole WG, Haynes R, Hecht JT. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">112</span>:1–5.</span> [<a href="/pubmed/12239711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12239711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hameetman.2007.396">Hameetman L, Szuhai K, Yavas A, Knijnenburg J, van Duin M, van Dekken H, Taminiau AH, Cleton-Jansen AM, Bov&#x000e9;e JV, Hogendoorn PC. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. <span><span class="ref-journal">J Natl Cancer Inst. </span>2007;<span class="ref-vol">99</span>:396–406.</span> [<a href="/pubmed/17341731" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17341731</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hattori.2006.405">Hattori H, Asagai Y, Yamamoto K. Sudden onset of saphenous neuropathy associated with hereditary multiple exostoses. <span><span class="ref-journal">J Orthop Sci. </span>2006;<span class="ref-vol">11</span>:405–8.</span> [<a href="/pubmed/16897208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16897208</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hecht.1997.80">Hecht JT, Hogue D, Wang Y, Blanton SH, Wagner M, Strong LC, Raskind W, Hansen MF, Wells D. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">60</span>:80–6.</span> [<a href="/pmc/articles/PMC1712567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1712567</span></a>] [<a href="/pubmed/8981950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8981950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hennekam.1991.262">Hennekam RC. Hereditary multiple exostoses. <span><span class="ref-journal">J Med Genet. </span>1991;<span class="ref-vol">28</span>:262–6.</span> [<a href="/pmc/articles/PMC1016830/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016830</span></a>] [<a href="/pubmed/1856833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1856833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.hussain.2010.51">Hussain W, Avedian R, Terry M, Peabody T. Solitary osteochondroma of the proximal femur and femoral acetabular impingement. <span><span class="ref-journal">Orthopedics. </span>2010;<span class="ref-vol">33</span>:51.</span> [<a href="/pubmed/20055356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20055356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.ishikawa.2007.1238">Ishikawa J, Kato H, Fujioka F, Iwasaki N, Suenaga N, Minami A. Tumor location affects the results of simple excision for multiple osteochondromas in the forearm. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2007;<span class="ref-vol">89</span>:1238–47.</span> [<a href="/pubmed/17545427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17545427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.jennes.2011.85">Jennes I, de Jong D, Mees K, Hogendoorn PC, Szuhai K, Wuyts W. Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families. <span><span class="ref-journal">BMC Med Genet. </span>2011;<span class="ref-vol">12</span>:85.</span> [<a href="/pmc/articles/PMC3152881/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3152881</span></a>] [<a href="/pubmed/21703028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21703028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.jennes.2008.85">Jennes I, Entius MM, Van Hul E, Parra A, Sangiorgi L, Wuyts W. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. <span><span class="ref-journal">J Mol Diagn. </span>2008;<span class="ref-vol">10</span>:85–92.</span> [<a href="/pmc/articles/PMC2175547/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2175547</span></a>] [<a href="/pubmed/18165274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18165274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.jennes.2012.148">Jennes I, Zuntini M, Mees K, Palagani A, Pedrini E, De Cock G, Fransen E, Vanden Berghe W, Sangiorgi L, Wuyts W. Identification and functional characterization of the human EXT1 promoter region. <span><span class="ref-journal">Gene. </span>2012;<span class="ref-vol">492</span>:148–59.</span> [<a href="/pubmed/22037484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22037484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.jennes.2009.1620">Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L, Wuyts W. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:1620–7.</span> [<a href="/pubmed/19810120" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19810120</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.jones.2010.2054">Jones KB, Piombo V, Searby C, Kurriger G, Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA, Capecchi MR, Vortkamp A, Sheffield VC. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:2054–9.</span> [<a href="/pmc/articles/PMC2836675/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2836675</span></a>] [<a href="/pubmed/20080592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20080592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.krooth.1961.340">Krooth RS, Macklin MT, Hislbish TF. Diaphysial aclasis (multiple exostoses) on Guam. <span><span class="ref-journal">Am J Hum Genet. </span>1961;<span class="ref-vol">13</span>:340–7.</span> [<a href="/pmc/articles/PMC1932089/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1932089</span></a>] [<a href="/pubmed/13754517" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13754517</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.le_merrer.1994.717">Le Merrer M, Legeai-Mallet L, Jeannin PM, Horsthemke B, Schinzel A, Plauchu H, Toutain A, Achard F, Munnich A, Maroteaux P. A gene for hereditary multiple exostoses maps to chromosome 19p. <span><span class="ref-journal">Hum Mol Genet. </span>1994;<span class="ref-vol">3</span>:717–22.</span> [<a href="/pubmed/8081357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8081357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.legeaimallet.1997.12">Legeai-Mallet L, Munnich A, Maroteaux P, Le Merrer M. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. <span><span class="ref-journal">Clin Genet. </span>1997;<span class="ref-vol">52</span>:12–6.</span> [<a href="/pubmed/9272707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9272707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.malag_n.2001.205">Malag&#x000f3;n V. Development of hip dysplasia in hereditary multiple exostosis. <span><span class="ref-journal">J Pediatr Orthop. </span>2001;<span class="ref-vol">21</span>:205–11.</span> [<a href="/pubmed/11242251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11242251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.masada.1989.24">Masada K, Tsuyuguchi Y, Kawai H, Kawabata H, Noguchi K, Ono K. Operations for forearm deformity caused by multiple osteochondromas. <span><span class="ref-journal">J Bone Joint Surg Br. </span>1989;<span class="ref-vol">71</span>:24–9.</span> [<a href="/pubmed/2914999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2914999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.matsubara.2006.459">Matsubara H, Tsuchiya H, Sakurakichi K, Yamashiro T, Watanabe K, Tomita K. Correction and lengthening for deformities of the forearm in multiple cartilaginous exostoses. <span><span class="ref-journal">J Orthop Sci. </span>2006;<span class="ref-vol">11</span>:459–66.</span> [<a href="/pubmed/17013733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17013733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.matsumoto.2010.10932">Matsumoto K, Irie F, Mackem S, Yamaguchi Y. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:10932–7.</span> [<a href="/pmc/articles/PMC2890731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2890731</span></a>] [<a href="/pubmed/20534475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20534475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.mccormick.2000.668">McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:668–73.</span> [<a href="/pmc/articles/PMC15388/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15388</span></a>] [<a href="/pubmed/10639137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10639137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.mordenti.2013.556">Mordenti M, Ferrari E, Pedrini E, Fabbri N, Campanacci L, Muselli M, Sangiorgi L. Validation of a new multiple osteochondromas classification through Switching Neural Networks. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:556–60.</span> [<a href="/pubmed/23401177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23401177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.noonan.2002.120">Noonan KJ, Feinberg JR, Levenda A, Snead J, Wurtz LD. Natural history of multiple hereditary osteochondromatosis of the lower extremity and ankle. <span><span class="ref-journal">J Pediatr Orthop. </span>2002;<span class="ref-vol">22</span>:120–4.</span> [<a href="/pubmed/11744867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11744867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.ofiram.2004.371">Ofiram E, Porat S. Progressive subluxation of the hip joint in a child with hereditary multiple exostosis. <span><span class="ref-journal">J Pediatr Orthop B. </span>2004;<span class="ref-vol">13</span>:371–3.</span> [<a href="/pubmed/15599227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15599227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.ofiram.2008.11">Ofiram E, Eylon S, Porat S. Correction of knee and ankle valgus in hereditary multiple exostoses using the Ilizarov apparatus. <span><span class="ref-journal">J Orthop Traumatol. </span>2008;<span class="ref-vol">9</span>:11–5.</span> [<a href="/pmc/articles/PMC2656976/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2656976</span></a>] [<a href="/pubmed/19384475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19384475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.pandya.2006.e920">Pandya NK, Auerbach JD, Baldwin K, Lackman RD, Chin KR. Spinal cord compression in a patient with multiple hereditary exostoses caused by breast adenocarcinoma metastatic to osteochondromas of the spine: case report. <span><span class="ref-journal">Spine. </span>2006;<span class="ref-vol">31</span>:E920–4.</span> [<a href="/pubmed/17108823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17108823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.pedrini.2011.2294">Pedrini E, Jennes I, Tremosini M, Milanesi A, Mordenti M, Parra A, Sgariglia F, Zuntini M, Campanacci L, Fabbri N, Pignotti E, Wuyts W, Sangiorgi L. Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2011;<span class="ref-vol">93</span>:2294–302.</span> [<a href="/pubmed/22258776" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22258776</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.philippe.1997.520">Philippe C, Porter DE, Emerton ME, Wells DE, Simpson AH, Monaco AP. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:520–8.</span> [<a href="/pmc/articles/PMC1715939/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715939</span></a>] [<a href="/pubmed/9326317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.porter.2004.1041">Porter DE, Lonie L, Fraser M, Dobson-Stone C, Porter JR, Monaco AP, Simpson AH. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. <span><span class="ref-journal">J Bone Joint Surg Br. </span>2004;<span class="ref-vol">86</span>:1041–6.</span> [<a href="/pubmed/15446535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15446535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.roach.2009.1942">Roach JW, Klatt JW, Faulkner ND. Involvement of the spine in patients with multiple hereditary exostoses. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2009;<span class="ref-vol">91</span>:1942–8.</span> [<a href="/pubmed/19651953" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19651953</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.romeike.2007.1">Romeike BF, Wuyts W. Proximal chromosome 11p contiguous gene deletion syndrome phenotype: case report and review of the literature. <span><span class="ref-journal">Clin Neuropathol. </span>2007;<span class="ref-vol">26</span>:1–11.</span> [<a href="/pubmed/17290930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17290930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.ropero.2004.2753">Ropero S, Setien F, Espada J, Fraga MF, Herranz M, Asp J, Benassi MS, Franchi A, Patino A, Ward LS, Bov&#x000e9;e J, Cigudosa JC, Wim W, Esteller M. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:2753–65.</span> [<a href="/pubmed/15385438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15385438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.rupprecht.2011.89">Rupprecht M, Spiro AS, Rueger JM, St&#x000fc;cker R. Temporary screw epiphyseodesis of the distal tibia: a therapeutic option for ankle valgus in patients with hereditary multiple exostosis. <span><span class="ref-journal">J Pediatr Orthop. </span>2011;<span class="ref-vol">31</span>:89–94.</span> [<a href="/pubmed/21150737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21150737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.schmale.1994.986">Schmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. <span><span class="ref-journal">J Bone Joint Surg Am. </span>1994;<span class="ref-vol">76</span>:986–92.</span> [<a href="/pubmed/8027127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8027127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.senay.2000.282">Senay C, Lind T, Muguruma K, Tone Y, Kitagawa H, Sugahara K, Lidholt K, Lindahl U, Kusche-Gullberg M. The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. <span><span class="ref-journal">EMBO Rep. </span>2000;<span class="ref-vol">1</span>:282–6.</span> [<a href="/pmc/articles/PMC1083719/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1083719</span></a>] [<a href="/pubmed/11256613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11256613</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.shah.2007.110">Shah ZK, Peh WC, Wong Y, Shek TW, Davies AM. Sarcomatous transformation in diaphyseal aclasis. <span><span class="ref-journal">Australas Radiol. </span>2007;<span class="ref-vol">51</span>:110–9.</span> [<a href="/pubmed/17419854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17419854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.shin.2006.255">Shin EK, Jones NF, Lawrence JF. Treatment of multiple hereditary osteochondromas of the forearm in children: a study of surgical procedures. <span><span class="ref-journal">J Bone Joint Surg Br. </span>2006;<span class="ref-vol">88</span>:255–60.</span> [<a href="/pubmed/16434534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16434534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.shin.2009.132">Shin SJ, Kwak HS, Cho TJ, Park MS, Yoo WJ, Chung CY, Choi IH. Application of Ganz surgical hip dislocation approach in pediatric hip diseases. <span><span class="ref-journal">Clin Orthop Surg. </span>2009;<span class="ref-vol">1</span>:132–7.</span> [<a href="/pmc/articles/PMC2766743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2766743</span></a>] [<a href="/pubmed/19885048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19885048</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.signori.2007.470">Signori E, Massi E, Matera MG, Poscente M, Gravina C, Falcone G, Rosa MA, Rinaldi M, Wuyts W, Seripa D, Dallapiccola B, Fazio VM. A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2007;<span class="ref-vol">46</span>:470–7.</span> [<a href="/pubmed/17301954" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17301954</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.szuhai.2011.e2036">Szuhai K, Jennes I, de Jong D, Bov&#x000e9;e JV, Wiweger M, Wuyts W, Hogendoorn PC. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:E2036–49.</span> [<a href="/pubmed/21280143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21280143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.tompkins.2012.e23">Tompkins M, Eberson C, Ehrlich M. Hemiepiphyseal stapling for ankle valgus in multiple hereditary exostoses. <span><span class="ref-journal">Am J Orthop (Belle Mead NJ). </span>2012;<span class="ref-vol">41</span>:E23–6.</span> [<a href="/pubmed/22482098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22482098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.van_hul.1998.230">Van Hul W, Wuyts W, Hendrickx J, Speleman F, Wauters J, De Boulle K, Van Roy N, Bossuyt P, Willems PJ. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. <span><span class="ref-journal">Genomics. </span>1998;<span class="ref-vol">47</span>:230–7.</span> [<a href="/pubmed/9479495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9479495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.viala.2012.1637">Viala P, Vanel D, Larbi A, Cyteval C, Laredo JD. Bilateral ischiofemoral impingement in a patient with hereditary multiple exostoses. <span><span class="ref-journal">Skeletal Radiol. </span>2012;<span class="ref-vol">41</span>:1637.</span> [<a href="/pubmed/22865159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22865159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.vujic.2004.47">Vujic M, Bergman A, Romanus B, Wahlstrom J, Martinsson T. Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes. <span><span class="ref-journal">Int J Mol Med. </span>2004;<span class="ref-vol">13</span>:47–52.</span> [<a href="/pubmed/14654969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14654969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.watts.2007.667">Watts AC, Ballantyne JA, Fraser M, Simpson AH, Porter DE. The association between ulnar length and forearm movement in patients with multiple osteochondromas. <span><span class="ref-journal">J Hand Surg [Am] </span>2007;<span class="ref-vol">32</span>:667–73.</span> [<a href="/pubmed/17482006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17482006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.wise.1997.10">Wise CA, Clines GA, Massa H, Trask BJ, Lovett M. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. <span><span class="ref-journal">Genome Res. </span>1997;<span class="ref-vol">7</span>:10–6.</span> [<a href="/pubmed/9037597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9037597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.wuyts.2005.542">Wuyts W, Radersma R, Storm K, Vits L. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:542–7.</span> [<a href="/pubmed/16283885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16283885</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.wuyts.1997.382">Wuyts W, Van Hul W, Hendrickx J, Speleman F, Wauters J, De Boulle K, Van Roy N, Van Agtmael T, Bossuyt P, Willems PJ. Identification and characterization of a novel member of the EXT gene family, EXTL2. <span><span class="ref-journal">Eur J Hum Genet. </span>1997;<span class="ref-vol">5</span>:382–9.</span> [<a href="/pubmed/9450183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9450183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ext.REF.zuntini.2010.3827">Zuntini M, Pedrini E, Parra A, Sgariglia F, Gentile FV, Pandolfi M, Alberghini M, Sangiorgi L. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation. <span><span class="ref-journal">Oncogene. </span>2010;<span class="ref-vol">29</span>:3827–34.</span> [<a href="/pubmed/20418910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20418910</span></a>]</div></li></ul></div></div><div id="ext.Chapter_Notes"><h2 id="_ext_Chapter_Notes_">Chapter Notes</h2><div id="ext.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 September 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 September 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 July 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 August 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>22 March 2000 (hc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1235</span><span class="label">PMID: <a href="/pubmed/20301413" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301413</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/accpn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hmerf/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1235&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1235/?report=reader">PubReader</a></li><li><a href="/books/NBK1235/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1235" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1235" style="display:none" title="Cite this Page"><div class="bk_tt">Wuyts W, Schmale GA, Chansky HA, et al. Hereditary Multiple Osteochondromas. 2000 Aug 3 [Updated 2013 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1235/pdf/Bookshelf_NBK1235.pdf">PDF version of this page</a> (477K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ext.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ext.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ext.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ext.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ext.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ext.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ext.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ext.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ext.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ext.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ext.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2131[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EXT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2132[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EXT2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1481396" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1481396" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1481396" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1481396" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28053536" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas.</a><span class="source">[Ther Clin Risk Manag. 2017]</span><div class="brieflinkpop offscreen_noflow">Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Akbaroghli S, Balali M, Kamalidehghan B, Saber S, Aryani O, Meng GY, Houshmand M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ther Clin Risk Manag. 2017; 13:15-19. Epub 2016 Dec 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29541207" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel exostosin-2 mutation identified in a Chinese family with hereditary multiple osteochondroma.</a><span class="source">[Oncol Lett. 2018]</span><div class="brieflinkpop offscreen_noflow">Novel exostosin-2 mutation identified in a Chinese family with hereditary multiple osteochondroma.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ruan W, Cao L, Chen Z, Kong M, Bi Q. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oncol Lett. 2018 Apr; 15(4):4383-4389. Epub 2018 Jan 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27920806" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.</a><span class="source">[Clin Cases Miner Bone Metab. 2...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Beltrami G, Ristori G, Scoccianti G, Tamburini A, Capanna R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Cases Miner Bone Metab. 2016 May-Aug; 13(2):110-118. Epub 2016 Oct 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24532482" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses.</a><span class="source">[J Appl Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jamsheer A, Socha M, Sowińska-Seidler A, Telega K, Trzeciak T, Latos-Bieleńska A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Appl Genet. 2014 May; 55(2):183-8. Epub 2014 Feb 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18328980" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary multiple exostoses and enchondromatosis.</a><span class="source">[Best Pract Res Clin Rheumatol....]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary multiple exostoses and enchondromatosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pannier S, Legeai-Mallet L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Best Pract Res Clin Rheumatol. 2008 Mar; 22(1):45-54. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301413" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301413" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410c175f66d18aad73662">Hereditary Multiple Osteochondromas - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hereditary Multiple Osteochondromas - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:45:37-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CF0B0E0404AD100000000051101B8&amp;ncbi_session=CE8CF0B0E0410C01_1297SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1235%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1235&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1235/&amp;ncbi_pagename=Hereditary Multiple Osteochondromas - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CF0B0E0410C01_1297SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>